Topic: St. Paul (Minnesota)

ST. Jude medical gets FDA, CE Mark approval for QuickFlex family of leads

Forbes - 1476 days ago
St. Jude Medical Inc. said Tuesday it has received Food and Drug Administration and European CE Mark approval for its QuickFlex family of left-heart leads to treat heart failure patients.. Shares of St. Paul, Minn.-based St. Jude fell 20 cents to $39.79.. ...